IL17A and myocardial infarction: Despite the findingthat infarct size 24 hours after surgery was comparable among all mice including WT,ablation of IL-23, IL-17A, or γδT cells improved survival after 7days, limited infarct expansion, and reduced fibrosis in the noninfarctedmyocardium, alleviating LV dilatation and systolic dysfunction on day 28 post-MI.IL-17A was not involved in the acute inflammatory response on day 2 post-MI.